Latest Post

June 04, 2019

Are You Ready? Compliance with New USP Chapters <381>, <382>, <1381> and <1382>

It is imperative for the pharmaceutical industry to be prepared to comply with new compendia chapters as soon as they are enacted. This comprises both knowing of proposed changes as soon as announced and being well prepared to accommodate them. USP Chapter &lt;381&gt; is changing, and Chapters &lt;382&gt;, &lt;1382&gt; and &lt;1381&gt; are being created. The Pharmacopeia Forum for final comments has been published.
Daniel Bantz

Daniel Bantz

Technical Manager, Packaging & Performance, Laboratory

Previous Posts
SmartDose Platform

April 26, 2019

Overcoming Challenges Associated with Biologic Drug Formulation and Development

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

What's New In the West Knowledge Center

April 16, 2019

What’s New in the Knowledge Center?

Tara Haarlander

Tara Haarlander

Sr. Specialist, Scientific Communications

Lab Testing

September 05, 2017

Spotlight on West’s Health and Safety Programs

Elizabeth Crawford

Elizabeth Crawford

Exton Communications Team Intern

integrity logo

June 29, 2017

West Reports on Corporate Responsibility for 2016

Elizabeth Crawford

Elizabeth Crawford

Exton Communications Team Intern

Mixject

April 28, 2017

Future Readiness - Compliance with New USP Chapter <382>

Daniel Bantz

Daniel Bantz

Tech Manager, Packaging & Performance, Laboratory

Blue West logo with Diamond

April 16, 2014

New FDA Guidance Issued for Annual Reportable Changes

Steve LoCastro

Steve LoCastro

Director, Regulatory Affairs

Blue West logo with Diamond

March 24, 2014

The Future of Aseptic Sterile Product Preparation Is Here!

West Pharma

Joanne Neizer

Technical Customer Support Specialist

Blue West logo with Diamond

August 28, 2013

FDA Issues Draft Guidance on Glass Syringe Connectivity

West Pharma

Graham Reynolds

Vice President & General Manager, Biologics

West logo with Diamond

March 08, 2012

Supply Chain Integrity Reduces Threats of Counterfeit Drug Products

West Pharma

Fran DeGrazio

VP, Scientific Affairs & Technical Services